Search Results 1581-1590 of 20038 for Hepatitis b

1. Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults - Mayo Clinic

   For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable or on suppressive therapy, if indicated.

2. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   HIV, hepatitis B, hepatitis C, or tuberculosis (TB) infection; Participated in a clinical study with an investigational drug or biologic within the last 30 ...

3. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

   Patients who have active, chronic, or on active treatment for Hep B or Hep C are excluded. Patients who have received a live attenuated vaccine with in 30 ...

4. Gynecological care for trans men - Mayo Clinic

   Vaccines can protect you from hepatitis A and hepatitis B. These serious liver infections can spread through sexual contact. HPV also can be passed to you ...

5. A Study Of ATR-101 For The Treatment Of Cushing’s Syndrome - Mayo Clinic

   HIV, hepatitis B, or hepatitis C positivity at screening; Any malignancy within the previous 10 years, other than curatively resected basal or squamous cell ...

6. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients - Mayo Clinic

   Has known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [qualitative] is detected). Has received a live vaccine within 30 days ...

7. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   ... Hepatitis B or Hepatitis C; Chemotherapy, radiotherapy, biologics, and/or other treatment with immunotherapy not completed four (4) weeks prior to first dose ...

8. A Study to Compare Nivolumab or Brentuximab Vedotin Plus Combination Chemotherapy to Treat Patients with Newly-diagnosed Stage III-IV Classic Hodgkin Lymphoma - Mayo Clinic

   Patients must not have known active hepatitis B (HBV) or hepatitis C virus (HCV) at date of registration. Patients with previously treated HBV or HCV that ...

9. Deucravacitinib (oral route) - Side effects & dosage - Mayo Clinic

   Liver disease (eg, hepatitis B or C) or; Tuberculosis, history of—Use with caution. May make these conditions worse. Infection, active or; Liver disease ...

10. A Study to Evaluate the Safety and Effectiveness of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease - Mayo Clinic

    Hepatitis B. Subject has positive test results for Human Immunodeficiency Virus (HIV) or known to be HIV-positive. Phase 1b subject cannot be a current ...